SCHEMBL2782201

SCHEMBL2782201

CCOC(=O)c1cc(Br)cc2c(C3CCS(=O)(=O)C(c4ccccc4)C3)cn(C(=O)O)c12

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 3/20 0.34
MAPT P10636 3/20 0.34
TP53 P04637 1/20 0.34
RORC P51449 1/20 0.34
CASP3 P42574 1/20 0.33
LMNA P02545 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
RXFP1 Q9HBX9 1/20 0.33
ELANE P08246 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
AR P10275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL621703 0.91 HPGD (0.36) HRH2MAPTTP53RORCCASP3
SCHEMBL2781073 0.85 LMNA (0.32) LMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL2782266 0.82 BRD4 (0.41) HRH2MAPTCASP3LMNAALDH1A1
SCHEMBL620435 0.81 NR1H2 (0.36) RORCCYP2C9CYP2C19
SCHEMBL2784294 0.81 LMNA (0.34) HRH2MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL2784968 0.79 IKBKB (0.37) LMNAALDH1A1SMN1; SMN2ELANE
SCHEMBL10211420 0.79 RORC (0.37) MAPTRORC
SCHEMBL2784293 0.79 LMNA (0.34) HRH2MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL2782280 0.79 HRH2 (0.33) HRH2MEN1KMT2ARXFP1
SCHEMBL2785428 0.79 LMNA (0.36) HRH2MAPTLMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139322-A1 INDOLE CARBOXAMIDES AS IKK2 INHIBITORS Smithkline Beecham Corporation (US) 2010-01-06 EP disclosed
WO-2008118724-A1 INDOLE CARBOXAMIDES AS IKK2 INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-10-02 WO disclosed